Vitreo-Retinal Associates

What Vitreo-Retinal Associates does

Vitreo-Retinal Associates, PC (VRA) is a private, physician-owned subspecialty ophthalmology practice founded in 1980 in Worcester, Massachusetts by Dr. Melvyn Defrin. The practice provides comprehensive medical and surgical care for diseases of the retina and vitreous, including age-related macular degeneration, diabetic retinopathy, retinal vein and artery occlusions, retinal detachments and tears, macular holes, macular pucker, retinitis pigmentosa, uveitis, and pediatric retinal conditions. Its clinical core centers on board-certified, fellowship-trained retina specialists delivering services from two office locations in Worcester and Leominster, Massachusetts, with hospital operating room access for major surgical procedures.

The practice deploys a standard but well-equipped diagnostic imaging stack — OCT, fluorescein angiography, fundus photography, ophthalmic ultrasound (B-scan), Humphrey visual field, Heidelberg Retinal Tomography, Optos and Clarus ultra-widefield imaging, and ICG angiography — alongside a NextGen electronic medical record and patient portal. A distinguishing element is its long-standing participation in FDA- and NIH-overseen clinical trials covering AMD, diabetic macular edema, geographic atrophy, and retinal vein occlusion, with multiple senior physicians serving as Leading Investigators on national studies.

VRA generates revenue through professional services billing for consultations, diagnostic testing, laser surgery, intravitreal injections, and vitrectomy, reimbursed primarily through major commercial insurers, Medicare, and Medicaid, with patient co-pays and deductibles collected at the time of service. The practice is independent, with no external investors or parent company, and ownership is distributed among the practicing physician partners. Patient acquisition is driven by referrals from primary care physicians and general ophthalmologists, word-of-mouth, the practice website, and the clinical trials program, which functions as both a revenue channel and a patient acquisition point.

Name

Vitreo-Retinal Associates

Legal name

Vitreo-Retinal Associates, PC

Website

https://retina-docs.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

1–10 employees

Short description

Vitreo-Retinal Associates is a private, physician-owned subspecialty ophthalmology practice in Central Massachusetts that diagnoses and surgically treats retinal and vitreous diseases in adult and pediatric patients, with two offices in Worcester and Leominster and active participation in FDA/NIH clinical trials.

Ownership category

akta.pro rank

Product category

Retinal Ophthalmology Services

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Retina & Vitreous Specialists (HLAKAKAE)

akta.pro secondary industry

Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)

Keywords

• Retinal disease treatment
• Vitreo-retinal surgery
• Ophthalmology services
• Retinal imaging diagnostics
• Clinical trials ophthalmology

Headquarters

HQ city

Worcester

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Patient Care Services: Medical practice providing specialized vitreo-retinal care including consultations, diagnostic testing, laser surgery, intravitreal injections, vitrectomy, and other surgical procedures. Revenue is generated through billable medical services billed to insurance providers and patients.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Vitreo-Retinal Associates is a private ophthalmology subspecialty practice that diagnoses and treats diseases of the retina and vitreous in adult and pediatric patients. The practice delivers medical and surgical care — including laser surgery, intravitreal injections, vitrectomy, scleral buckling, and pneumatic retinopexy — supported by advanced diagnostic imaging (OCT, fluorescein angiography, fundus photography, ophthalmic ultrasound, visual field analysis). The practice is also an active participant in FDA- and NIH-overseen national clinical trials testing new therapies for retinal disease.

Product overview

Vitreo-Retinal Associates is a specialized ophthalmology practice providing comprehensive retinal care services. The practice operates as a single-service medical group offering: retinal disease diagnosis and treatment for conditions such as macular degeneration, diabetic retinopathy, and retinal detachment; surgical procedures including vitrectomy, laser surgery, and intravitreal injections; an active clinical trials program participating in FDA/NIH-supervised studies; and advanced diagnostic imaging services using OCT, fluorescein angiography, fundus photography, and ultrasound technology. The practice also provides a NextGen patient portal for PHI access. Founded in 1980, the practice has two locations in Worcester and Leominster, Massachusetts.

Differentiator

Problem solved

Functional benefit

Products and services

• Retinal Disease Diagnosis & Treatment Services Comprehensive medical and surgical diagnosis and treatment of retinal diseases and disorders including age-related macular degeneration, retinal vein and artery occlusions, diabetic retinopathy, retinal tears and detachments, macular holes, macular puckers, retinitis pigmentosa, eye trauma, uveitis, and cataract complications — provided to adult and pediatric patients referred by primary care physicians and general ophthalmologists.
• Surgical Procedures In-office and hospital-based surgical procedures for retinal disease including retinal detachment repair (scleral buckling, pneumatic retinopexy, vitrectomy), vitrectomy surgery, intravitreal injections, and laser surgery — delivered to patients with retinal tears, detachments, macular holes, epiretinal membranes, diabetic retinopathy, and other vitreo-retinal conditions.
• Clinical Trials Program Active participation in FDA- and NIH-overseen national clinical trials testing new medications, devices, and interventions for retinal diseases including AMD, diabetic macular edema, geographic atrophy, and retinal vein occlusion — providing patients access to cutting-edge treatments before they are widely available.
• Advanced Retinal Imaging State-of-the-art diagnostic imaging services including Optical Coherence Tomography (OCT) for high-resolution retinal layer imaging, fluorescein angiography for retinal and choroidal blood flow assessment, fundus photography for diagnosis and monitoring, ophthalmic ultrasound (B-scan) for evaluation when the retina or vitreous cannot be visualized, and Humphrey visual field analysis for peripheral vision assessment.
• Specialized Diagnostic Testing Additional specialized diagnostic tests including Heidelberg Retinal Tomography, Optos ultra-widefield photography, Clarus widefield photography, TopCon fundus photography, Humphrey Visual Field Analysis, and Indocyanine Green Angiography (ICG) — used to diagnose and monitor complex retinal conditions during patient visits.
• Patient Portal NextGen electronic patient portal enabling patients to access their Protected Health Information (PHI) online, manage appointments, and communicate with the practice.

Quantifiable outcome

• Clinical trials may improve length and quality of life for participants who have access to cutting-edge treatments before they are widely available.

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Bascom Palmer Eye Institute: Top-ranked academic ophthalmology institute where associate Dr. Rodriguez trained; offers vitreo-retinal specialty services and clinical research overlapping with VRA's niche.
• Wills Eye Hospital: Premier US ophthalmology specialty hospital where founding partners completed fellowship training; provides benchmark vitreo-retinal clinical and surgical care, clinical trial leadership, and fellowship training comparable to VRA's specialty offerings.
• Massachusetts Eye and Ear: Harvard-affiliated specialty hospital delivering the full spectrum of vitreo-retinal medicine and surgery including fellowship training; a leading regional incumbent providing overlapping specialty care.
• New England Eye Center (Tufts): Academic multi-specialty ophthalmology center affiliated with Tufts, providing vitreo-retinal care alongside comprehensive ophthalmology services and clinical research in the same New England market.

Direct peers

• California Retina Consultants: Large vitreo-retinal specialty practice with multiple California locations actively participating in national retinal clinical trials, providing directly comparable specialty surgical and medical retina services.
• Mid Atlantic Retina: Specialty vitreo-retinal practice group with multiple locations in the Mid-Atlantic, offering medical retina, surgery, and clinical trial participation — closely mirroring VRA's specialty-only model outside its immediate geography.
• Ophthalmic Consultants of Boston: Multi-specialty ophthalmology and vitreo-retinal practice in the greater Boston area, offering surgical, medical retina, and clinical trial services closely comparable to Vitreo-Retinal Associates' regional specialty model.
• Retina Consultants of Texas: Multi-site vitreo-retinal specialty practice across Texas with leading clinical trial participation; a regional specialty peer matching VRA's model of consolidated retina care delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/vitreo-retinal-associates-of-worcester-pc

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vitreo-Retinal Associates